Clinical Trials Browser

IFL protocol × Endocrine × Clear all

NCT02820857 2025-09-03

BEVANEC

Phase 2 Completed

Carcinoma, Neuroendocrine

NCT05879055 2024-12-19

A Study of PM8002 in Combination With Chemotherapy in Patients With NEN

Phase 2 Recruiting

Neuroendocrine Tumors

NCT03168607 2017-06-01

Study to Evaluate the Efficiency of FOLFIRI as Seconde-line Chemotherapy in Neuroendocrine Carcinoma

Phase 2 Unknown

Carcinoma, Neuroendocrine